Advantage Dog 250 250 mg/2.5 ml Solution pour application cutanée
Advantage Dog 250 250 mg/2.5 ml Solution pour application cutanée
Authorised
- Imidacloprid
Product identification
Medicine name:
Advantage Dog 250 250 mg/2.5 ml Solution pour application cutanée
Active substance:
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Imidacloprid250.00/milligram(s)2.50millilitre(s)
Pharmaceutical form:
-
Cutaneous solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX17
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Advantage Dog 250 2 2.5 ml Pipette Cutaneous solution
- Advantage Dog 250 3 2.5 ml Pipette Cutaneous solution
- Advantage Dog 250 4 2.5 ml Pipette Cutaneous solution
- Advantage Dog 250 6 2.5 ml Pipette Cutaneous solution
Additional information
Entitlement type:
-
Marketing Authorisation
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 442/14/03/1356
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
